AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 93 filers reported holding AVROBIO INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $4,000 | -66.7% | 3,029 | 0.0% | 0.00% | – |
| Q4 2021 | $12,000 | -82.1% | 3,029 | -74.9% | 0.00% | – |
| Q3 2021 | $67,000 | +48.9% | 12,058 | +138.0% | 0.00% | – |
| Q2 2021 | $45,000 | -44.4% | 5,066 | -21.0% | 0.00% | – |
| Q1 2021 | $81,000 | +32.8% | 6,411 | +46.8% | 0.00% | – |
| Q4 2020 | $61,000 | +7.0% | 4,367 | 0.0% | 0.00% | – |
| Q3 2020 | $57,000 | -42.4% | 4,367 | -22.6% | 0.00% | – |
| Q2 2020 | $99,000 | +43.5% | 5,640 | +28.9% | 0.00% | – |
| Q1 2020 | $69,000 | -28.9% | 4,374 | -9.6% | 0.00% | – |
| Q4 2019 | $97,000 | +73.2% | 4,837 | +21.5% | 0.00% | – |
| Q3 2019 | $56,000 | +14.3% | 3,982 | +24.6% | 0.00% | – |
| Q2 2019 | $49,000 | +4.3% | 3,197 | +50.0% | 0.00% | – |
| Q1 2019 | $47,000 | +213.3% | 2,131 | +132.1% | 0.00% | – |
| Q4 2018 | $15,000 | -68.8% | 918 | 0.0% | 0.00% | – |
| Q3 2018 | $48,000 | – | 918 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,417,204 | $28,528,000 | 17.28% |
| Aisling Capital Management LP | 893,079 | $17,978,000 | 6.89% |
| AlpInvest Partners B.V. | 200,732 | $4,041,000 | 3.44% |
| TANG CAPITAL MANAGEMENT LLC | 1,000,000 | $20,130,000 | 2.40% |
| New Leaf Venture Partners, L.L.C. | 315,550 | $6,352,000 | 1.38% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,164,970 | $23,451,000 | 0.75% |
| Eventide Asset Management | 1,305,307 | $26,276,000 | 0.74% |
| Camber Capital Management LP | 600,000 | $12,078,000 | 0.62% |
| EMERALD ADVISERS, LLC | 656,306 | $13,211,000 | 0.56% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 641,387 | $12,911,000 | 0.53% |